According to Novocure 's latest financial reports the company's total debt is $0.59 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.59 B | 2.05% |
2022-12-31 | $0.58 B | 1.57% |
2021-12-31 | $0.57 B | 29.49% |
2020-12-31 | $0.44 B | 171.57% |
2019-12-31 | $0.16 B | 9.58% |
2018-12-31 | $0.14 B | 52.37% |
2017-12-31 | $97.96 M | 1.24% |
2016-12-31 | $96.76 M | 318.95% |
2015-12-31 | $23.09 M | 7095.33% |
2014-12-31 | $0.32 M | -7.23% |
2013-12-31 | $0.34 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $1.5 M | -99.75% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $47.82 M | -91.98% | ๐ฌ๐ง UK |
Novavax NVAX | $0.22 B | -61.58% | ๐บ๐ธ USA |
Novocure
NVCR | $0.59 B | 0.00% | Jersey |